Havells India Ltd Analyst Rating
based on 35 analysts
55.88%
Buy
35.29%
Hold
8.82%
Sell
Based on 35 analysts offering long term price targets for Havells India Ltd. An average target of ₹1936.43
Source: S&P Global Market Intelligence
Havells India Ltd Share analysis
Havells India Ltd price forecast by 35 analysts
Upside of14.37%
High
₹2370
Target
₹1936.43
Low
₹1460
Havells India Ltd target price ₹1936.43, a slight upside of 14.37% compared to current price of ₹1657.4. According to 35 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Havells India Ltd revenue growth forecast
Expected growth rate Q1, FY2026:34.03%
Forecast
Actual
Including amortisation and stock based compensations
Havells India Ltd EPS growth forecast
EPS estimate Q1, FY2026:51.08%
Forecast
Actual
Source: S&P Global Market Intelligence
Havells India Ltd Performance
Day's Low
Day's High
₹1,650Day's Price Range₹1,712.952 Week's Low
52 Week's High
₹1,28052-Week Price Range₹2,106
| Returns % | |
| 1 Month Return | + 3.49 % |
| 3 Month Return | -18.69 % |
| 1 Year Return | + 26.25 % |
| Market Stats | |
| Previous Close | ₹1,693.15 |
| Open | ₹1,693.15 |
| Volume | 7.35L |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹1,06,395.15Cr |
Havells India Ltd Key Statistics
| P/E Ratio | 75.28 |
| PEG Ratio | 20.35 |
| Market Cap | ₹1,06,395.15 Cr |
| P/B Ratio | 12.76 |
| EPS | 20.28 |
| Dividend Yield | 0.59 |
| Sector | Consumer Durables |
| ROE | 18.12 |
Havells India Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| BUY | ₹1,06,395.15 Cr | 32.11% | 0.53 | ₹1,270 Cr | ₹18,590 Cr | |
| BUY | ₹25,504.55 Cr | 12.46% | 0.61 | ₹441 Cr | ₹7,312 Cr | |
| BUY | ₹1,13,631.93 Cr | 471.96% | 0.58 | ₹374 Cr | ₹17,690 Cr | |
| HOLD | ₹58,136.45 Cr | 33.16% | 0.53 | ₹248 Cr | ₹12,481 Cr | |
| BUY | ₹24,682.91 Cr | -2.23% | 0.57 | ₹224 Cr | ₹6,829 Cr |
Havells India Ltd Mutual Fund Holdings
About Havells India Ltd
Havells has a strong presence in the consumer durables segment, offering products such as air coolers, air purifiers, fans, irons, mixer grinders, and more. Its popular brands include Havells, Crabtree, Standard, and Lloyd. Its industrial products include switchgear, cables & wires, and motors. The company also offers a range of lighting solutions, such as LED bulbs, tube lights, and street lights.
Share Price: ₹1657.40 per share as on 20 Dec, 2024 04:01 PM
Market Capitalisation: ₹1,06,395.15Cr as of today
Revenue: ₹4,539.31Cr as on September 2024 (Q3 24)
Net Profit: ₹267.77Cr as on September 2024 (Q3 24)
Listing date: 21 Mar, 2001
Chairperson Name: Anil Rai Gupta
| Organisation | Havells India Ltd |
| Headquarters | Noida |
| Industry | Consumer Durables |
| E-voting on shares | Click here to vote |
Key events for Havells India Ltd
Havells India Shares Rise Amid Mixed Financials - 26 Nov, 2024
Havells India shares rose 0.29% to Rs 1713.8. Despite a 21.27% drop in quarterly sales, the stock has gained 32.48% over the past year. Promoters hold 59.41% stake.Havells India Technical Analysis Indicates Potential Reversal - 25 Nov, 2024
Havells is currently in a corrective ABC phase after a 5-wave rally, nearing a critical support zone between Rs 1,630-1,650. This area aligns with key Fibonacci retracement levels and suggests a potential base formation. A double-bottom pattern and bullish divergence further support a possible reversal. Traders may consider long positions within Rs 1,645-1,675, with a stop loss below Rs 1,560 and an upside target of Rs 1,825, indicating an attractive risk-to-reward ratio.Havells India Technical Analysis Indicates Potential Reversal - 23 Nov, 2024
Havells India is currently in a corrective phase after a 5-wave rally, nearing a critical support zone between Rs 1,630-1,650. Technical indicators suggest a potential reversal, with a target of Rs 1,825 and a stop-loss at Rs 1,560, offering an attractive risk-to-reward ratio for traders.Havells India Stock Shows Mixed Performance - 22 Nov, 2024
Havells India Ltd. shares traded at Rs 1664.95, up 1.93% from the previous close. The stock has a market cap of Rs 104,219.03 crore, with a P/E ratio of 73.88. It is currently below both its 50-DMA and 200-DMA, indicating a bearish trend. Promoter holding stands at 59.41%, while institutional investors own 28.7%. The stock's volatility is measured by a beta value of 1.1362.Havells India Invests in New Refrigerator Facility - 19 Nov, 2024
Havells India plans to invest Rs 480 crore to establish a refrigerator manufacturing facility in Rajasthan, aiming for a production capacity of 1.4 million units by Q2FY27. The investment is expected to enhance operational efficiency and reduce outsourcing.Havells Shows Potential for Reversal Amid Correction - 18 Nov, 2024
Havells India Ltd has corrected 25% recently, forming a double-bottom pattern near Rs 1,600-1,580. A bullish divergence suggests a potential reversal, with buying opportunities identified in the Rs 1,590-1,610 range, targeting Rs 1,760.Havells India Shows Potential for Reversal - 17 Nov, 2024
Havells has seen a 25% correction recently, forming a double-bottom pattern near Rs 1,600-1,580. A bullish divergence suggests a potential reversal, with buying opportunities identified in the Rs 1,590-1,610 range, targeting Rs 1,760.Janhvi Kapoor Promotes Havells Air Purifier - 28 Oct, 2024
Havells India Ltd partners with actress Janhvi Kapoor to promote its Meditate air purifier, utilizing SpaceTech technology for superior air purification. The campaign emphasizes the importance of clean air for a healthier lifestyle.
Insights on Havells India Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTMF Holding Up
Mutual Funds have increased holdings from 3.81% to 3.94% in Sep 2024 quarter
NO EFFECTAgainst Peers
In the last 3 years, Blue Star Ltd has given 304.9% return, outperforming this stock by 273.4%
- NO EFFECT
Against Peers
In the last 1 year, Blue Star Ltd has given 115.0% return, outperforming this stock by 91.3%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 59.41% of holdings in Sep 2024 quarter
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 446.7 Cr → 268.23 Cr (in ₹), with an average decrease of 21.5% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, HAVELLS stock has moved down by -15.1%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 5.67% to 5.59% in Sep 2024 quarter
- NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 5.88K Cr → 4.63K Cr (in ₹), with an average decrease of 21.3% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 25.33% to 24.76% in Sep 2024 quarter
News
Factors Behind the Rise in Dr Reddys Share Price
Recently, Dr Reddys share price has gained significant attention. Over the last five days, its share price surged 7.6%. Dr Reddys Laboratories is gaining attention due to its strategic focus on long-term growth and emerging markets. Despite underperforming against the Nifty Pharma Index over the last 1-5 years, international brokerage firms have upgraded their price targets for the company. This upgrade indicates confidence in Dr Reddys ability to overcome near-term hurdles and leverage future growth opportunities. The stocks recent challenges stem from heavy dependence on gRevlimid, whose sales are expected to decline by FY26, and increased overheads linked to rising investments in R&D, biosimilar trials, and manufacturing upgrades. These investments have led to temporary pressure on profit margins. For instance, earnings before interest, tax, depreciation, and amortisation (EBITDA) margins are forecasted to remain slightly under the pressure through FY27. However, analysts project accelerated earnings growth starting FY28 as new revenue streams such as GLP-1 APIs, biosimilars, and injectables mature. Dr Reddys is expanding its manufacturing infrastructure, focusing on high-demand areas like peptide APIs and injectables. It is also poised to capitalise on low-competition injectable launches in the US and growth in emerging markets, including India and Canada. The Canadian semaglutide market, estimated at US $ 1-1.5 billion (bn), offers a significant opportunity post the 2026 patent expiry. The companys ability to transition from near-term challenges to medium and long-term growth is driving investor optimism. Strategic investments, new market opportunities, and innovative initiatives position Dr Reddys for sustained growth, contributing to its recent share price surge. In the past five days, Dr Reddys share price is up 6.9%. In the last month, it has rallied 12.5%. In 2024, so far it has rallied 15.5%. Additionally, it surged 20.6% in the last year. The stock touched its 52-week high of Rs 1,420.2 on 21 August 2024 and a 52-week low of Rs 1,094.9 on 21 December 2023.20 Dec, 2024 06:13 PMStock Market Crash: Nifty Stocks with Positive Returns This Week
Dr Reddys Laboratories was recently upgraded by Nomura, with a price target of ₹1,500 per share. Nomura believes concerns about the high contribution of Revlimid have already been priced in. In the first half of the 2024-25 fiscal year, a large part of the companys growth was driven by initiatives, including clinical trials for biosimilars. The brokerage highlighted that Dr. Reddys Laboratories has significantly increased investments in manufacturing infrastructure, with its capex more than doubling in FY25. Moreover, the potential upside from GLP-1 and biosimilars has not been fully accounted for in FY27 estimates.20 Dec, 2024 04:48 PMIndian Equity Indices End Week Lower: Key Gainers and Losers
The top gainers on the Nifty included Dr. Reddys Laboratories, which surged by 1.49 per cent.20 Dec, 2024 04:12 PMHavells India Ltd Financials
Index Inclusions
Havells India Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 59.41% | 0.00 | |
| Foreign Institutions | 24.76% | ||
| Mutual Funds | 3.94% | 3.57 | |
| Retail Investors | 5.59% | ||
| Others | 6.3% | 8.88 |
Havells India Ltd Key Indicators
Havells India Ltd Valuation
Havells India Ltd in the last 5 years
Lowest (-356.62x)
January 23, 2018
Industry (-201.09x)
December 19, 2024
Today (75.28x)
December 19, 2024
Highest (416.33x)
August 31, 2018
Havells India Ltd Earnings and Dividends
Havells India Ltd Earnings Results
Havells India Ltd’s net profit jumped 7.69% since last year same period to ₹268.23Cr in the Q2 2024-2025. On a quarterly growth basis, Havells India Ltd has generated -34.24% fall in its net profits since last 3-months.
Read More about Earnings ResultsHavells India Ltd Dividends April,2024
In the quarter ending March 2024, Havells India Ltd has declared dividend of ₹6 - translating a dividend yield of 0.81%.
Read More about Dividends
Havells India Ltd Technicals Summary
Bearish
Neutral
Bullish
Havells India Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Havells India Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Havells India Ltd shares.
Havells India Ltd (HAVELLS) share price today is ₹1657.4
Havells India Ltd is listed on NSE
Havells India Ltd is listed on BSE
- Today’s highest price of Havells India Ltd is ₹1712.9.
- Today’s lowest price of Havells India Ltd is ₹1650.
PE Ratio of Havells India Ltd is 75.28
PE ratio = Havells India Ltd Market price per share / Havells India Ltd Earnings per share
Today’s traded volume of Havells India Ltd(HAVELLS) is 7.35L.
Today’s market capitalisation of Havells India Ltd(HAVELLS) is ₹106395.15Cr.
| Havells India Ltd(HAVELLS | Price |
|---|---|
52 Week High | ₹2106 |
52 Week Low | ₹1280 |
Havells India Ltd(HAVELLS) share price is ₹1657.4. It is down -21.30% from its 52 Week High price of ₹2106
Havells India Ltd(HAVELLS) share price is ₹1657.4. It is up 29.48% from its 52 Week Low price of ₹1280
| Havells India Ltd(HAVELLS | Returns |
|---|---|
1 Day Returns | -35.75% |
1 Month Returns | 3.49% |
3 Month Returns | -18.69% |
1 Year Returns | 26.25% |